Zomedica Corp. (TSX: $ZOMD.V) has seen significant stock movement recently, with a reported increase of 51% over the past two months. Investors are expressing optimism about the company's performance, particularly noting a sequential revenue growth of 20% quarter-over-quarter, despite the traditionally weak third quarter. Some investors have indicated that the stock's recent rise may still be in its early stages, suggesting further potential for growth. Overall, the sentiment among investors remains bullish, although there are indications of volatility in the stock's performance.